Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2017

01-03-2017 | Case Report

De Novo Inflammatory Bowel Disease After Bariatric Surgery: A Case Series and Literature Review

Authors: Gregory R. Bernstein, Octavia Pickett-Blakely

Published in: Digestive Diseases and Sciences | Issue 3/2017

Login to get access

Excerpt

Paralleling the alarming rise in rates of obesity and obesity-related comorbid conditions in the USA, the number of bariatric surgeries continues to increase in recent years, according to the American Society for Metabolic and Bariatric Surgery. Roux-en-Y gastric bypass (RYGB) is one of the most commonly performed bariatric surgeries in the USA. The two main mechanisms for weight loss with RYGB involve a combination of food restriction and bypass of absorptive and secretory components of the digestive tract. While the aforementioned mechanisms are effective in both induction and maintenance of sustained weight loss, unfortunately, they can lead to various complications as well. Such complications may be predominantly nutritional (micronutrient and macronutrient deficiencies, dehydration) or gastrointestinal (diarrhea, nausea, vomiting, abdominal pain, ulcers, strictures, gallstones, hernias) in nature [1]. To date, there have been only seven reported cases in the literature of new onset Crohn’s disease (CD) after gastrointestinal bypass surgery [14]. We present two cases of new onset CD after RYGB. …
Literature
1.
go back to reference Ahn LB, Huang CS, Forse RA, Hess DT, Andrews C, Farraye FA. Crohn’s disease after gastric bypass surgery for morbid obesity: is there an association? Inflamm Bowel Dis. 2005;11:622–624.CrossRefPubMed Ahn LB, Huang CS, Forse RA, Hess DT, Andrews C, Farraye FA. Crohn’s disease after gastric bypass surgery for morbid obesity: is there an association? Inflamm Bowel Dis. 2005;11:622–624.CrossRefPubMed
2.
go back to reference Dodell GB, Albu JB, Attia L, McGinty J, Pi-Sunyer FX, Laferrere B. The bariatric surgery patient: lost to follow-up; from morbid obesity to severe malnutrition. Endocr Pract. 2012;18:e21–e25.CrossRefPubMedPubMedCentral Dodell GB, Albu JB, Attia L, McGinty J, Pi-Sunyer FX, Laferrere B. The bariatric surgery patient: lost to follow-up; from morbid obesity to severe malnutrition. Endocr Pract. 2012;18:e21–e25.CrossRefPubMedPubMedCentral
4.
go back to reference Kotze PG, Bremer-Nones R, Kotze LM. Is there any relation between gastric bypass for morbid obesity and the development of Crohn’s disease? J Crohns Colitis. 2014;8:712–713.CrossRefPubMed Kotze PG, Bremer-Nones R, Kotze LM. Is there any relation between gastric bypass for morbid obesity and the development of Crohn’s disease? J Crohns Colitis. 2014;8:712–713.CrossRefPubMed
5.
6.
go back to reference Aminian A, Andalib A, Ver MR, Corcelles R, Schauer PR, Brethauer SA. Outcomes of bariatric surgery in patients with inflammatory bowel disease. Obes Surg. 2015;26:1186–1190.CrossRef Aminian A, Andalib A, Ver MR, Corcelles R, Schauer PR, Brethauer SA. Outcomes of bariatric surgery in patients with inflammatory bowel disease. Obes Surg. 2015;26:1186–1190.CrossRef
7.
go back to reference Lascano CA, Soto F, Carrodeguas L, Szomstein S, Rosenthal RJ, Wexner SD. Management of ulcerative colitis in the morbidly obese patient: is bariatric surgery indicated? Obes Surg. 2006;16:783–786.CrossRefPubMed Lascano CA, Soto F, Carrodeguas L, Szomstein S, Rosenthal RJ, Wexner SD. Management of ulcerative colitis in the morbidly obese patient: is bariatric surgery indicated? Obes Surg. 2006;16:783–786.CrossRefPubMed
Metadata
Title
De Novo Inflammatory Bowel Disease After Bariatric Surgery: A Case Series and Literature Review
Authors
Gregory R. Bernstein
Octavia Pickett-Blakely
Publication date
01-03-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4412-y

Other articles of this Issue 3/2017

Digestive Diseases and Sciences 3/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.